Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost
- 1 March 2005
- journal article
- Published by Elsevier BV in Journal of Critical Care
- Vol. 20 (1), 46-58
- https://doi.org/10.1016/j.jcrc.2004.10.005
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- An Economic Evaluation of Activated Protein C Treatment for Severe SepsisNew England Journal of Medicine, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shockIntensive Care Medicine, 1995
- Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe SepsisJAMA, 1995
- A review of cost studies of intensive care unitsCritical Care Medicine, 1995
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993
- Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patientsPublished by American Medical Association (AMA) ,1993
- Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agentPublished by American Medical Association (AMA) ,1991
- APACHE IICritical Care Medicine, 1985
- Therapeutic Intervention Scoring SystemCritical Care Medicine, 1983